Picture of Cyxone AB logo

CYXO — Cyxone AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Cyxone: Issuance Of US Divisional Patent For Drug Candidate T20K In MS

Feb 4 (Reuters) - Cyxone AB  CYXO.ST :
    * CYXONE ANNOUNCES ISSUANCE OF U.S. DIVISIONAL PATENT FOR
DRUG
CANDIDATE T20K IN MS
    * NEWLY ISSUED U.S. DIVISIONAL PATENT IS A SUB-PATENT TO
GRANTED
PATENT TITLED CYCLOTIDES AS IMMUNOSUPPRESSIVE AGENTS (US
9,453,052 B2)

Source text for Eikon:  ID:nWkr2cfQt5 
Further company coverage:  CYXO.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Cyxone AB

See all news